Retinol-binding protein 4 in adipose and placental tissue of women with gestational diabetes

Gynecological Endocrinology

Volumn 27, Issue 12, 2011, Pages 1065-1069

  Kuzmicki, Mariusz ^a   Telejko, Beata ^a   Wawrusiewicz Kurylonek, Natalia ^a   Nikolajuk, Agnieszka ^a   Zwierz Gugala, Dorota ^a   Jelski, Wojciech ^a   Kolodziejczak, Malgorzata ^a   Zonenberg, Anna ^a   Wilczynski, Jan ^b   Kretowski, Adam ^a   Gorska, Maria ^a   Szamatowicz, Jacek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

adipose tissue; gestational diabetes mellitus; glucose transporter 4; peroxisome proliferator activated receptor ; Retinol binding protein 4

Indexed keywords

GLUCOSE TRANSPORTER 4; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOL BINDING PROTEIN 4;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; PLACENTA; PREDICTION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADULT; BLOOD CHEMICAL ANALYSIS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INTRA-ABDOMINAL FAT; PLACENTA; PPAR GAMMA; PREGNANCY; RETINOL-BINDING PROTEINS, PLASMA; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 80955142482     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.579651     Document Type: Article

References (28)

1. Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 1989;308:308-316.
2. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362.
3. Tamori Y, Sakaue H, Kasuga M. RBP4, an unexpected adipokine. Nat Med 2006;12:30-31.
4. Graham TE, Yang Q, Blü her M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Obwerach A, Jansson PA, Smith U, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354: 2552-2563.
5. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007;92: 1971-1974.
6. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007;92:1168-1171.
7. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolnce and type 2 diabetes. Diabetes Care 2006; 29:2457-2461.
8. Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS. Raised serum, adipocyte and adipose tissue retinol binding protein 4 is in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 2007;92:2764-2772.
9. Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schon MR, Stumvoll M, Blü her M, et al. Serum retinol binding protein is more highly expressed in viscl than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007;6:79-87.
10. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007;30 (Suppl 2):S112-S119.
11. Chan TF, Chen TS, Chen YC, Lee GH, Chou FH, Chen IJ, Chen SY, IJong SB, Tsai EM. Increased serum retinolbinding protein 4 concentrations in women gestational diabetes mellitus. Reprod Sci 2007;14:169-174.
12. Kim SH, Choi HJ. Retinol-binding protein 4 responses during an oral glucose tolnce testing in women with gestational diabetes mellitus. Clin Chim Acta 2008;391:123-125.
13. Lewandowski KC, Stojanovic N, Bienkiewicz M, Tan BK, Prelevic GM, Pess M, Tuck S, O'Hare PJ, Randeva HS. Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol 2008;24:300-305.
14. Mazaki-Tovi S, Romero R, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Kim SK, Mittal P, Dong Z, Pacora P, Yeo L, et al. Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus. J Perinat Med 2010;38:147-155.
15. Klein K, Bancher-Todesca D, Leipold H, Knofler M, Haslinger P, Handisurya A, Kautzky-Willer A, Worda C. Retinol-binding protein 4 in patients with gestational diabetes mellitus. J Womens Health 2010;19:517-521
16. Choi SH, Kwak SH, Youn BS, Lim S, Park YJ, Lee H, Lee N, Cho YM, Lee HK, Kim YB, et al. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolnce in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2008;93:3142-3148.
17. Krzyzanowska K, Zemany L, Krugluger W, Schernthaner GH, Mittermayer F, Schnack C, Rahman R, Brix J, Kahn BB, Schernthaner G. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia 2008;51:1115-1122.
18. Janke J, Engeli S, Boschmann M, Adams F, Böhnke J, Luft JC, Sharma AM, Jordan J. Retinol-binding protein 4 in human obesity. Diabetes 2006;55:2805-2610.
19. WHO Consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus, WHO/NCD/NCS/99.2. Geneva: WHO; 1999.
20. Catalán V, Gómez-Ambrosi J, Rotellar F, Silva C, Rodríguez A, Salvador J, Gil MJ, Cienfuegos JA, Frü hbeck G. Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus. Horm Metab Res 2007;39:495-500.
21. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ III, Reshidi AA, et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007;92: 2590-2597.
22. Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P. Retinolbinding protein 4 in twins. Regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes 2009;58:54-60.
23. Shepherd PR, Kahn BB. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248-257.
24. Carvalho E, Jansson PA, Nagaev I, WEnthzel AM, Smith U. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulinstimulated glucose transport. FASEB J 2001;15:1101-1103.
25. Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters. Diabetes 1993;42:1773-1785.
26. Suwaki N, Masuyama H, Masumoto A, Takamoto N, Hiramatsu Y. Expression and potential role of peroxisome proliftor-activated receptor g in the placenta of diabetic pregnancy. Placenta 2007;28:315-323.
27. JawERaum A, Capobianco E, Pustovrh C, White V, Baier M, Salzberg S, Pesaresi M, Gonzalez E. Influence of peroxisome proliftor-activated receptor activation by its endogenous ligand 15-deoxy12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol Hum Reprod 2004;10:671-676.
28. Holdsworth-Carson SJ, Lim R, Mitton A, Whitehead C, Rice GE, Permezel M, Lappas M. Peroxisome proliftoractivatedreceptos are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 2010;31:222-229.